Pathfinders in Biopharma

Compass trials mark a milestone moment for the psychedelics sector


Listen Later

Compass Pathways CEO Kabir Nath believes psilocybin-based therapy could be transformational for patients with treatment-resistant depression—and his company is already preparing to deliver it at scale. Speaking at RBC Capital Markets’ Global Healthcare Conference, Nath shares his vision for Compass and the future of psilocybin therapy for treatment-resistant depression.

...more
View all episodesView all episodes
Download on the App Store

Pathfinders in BiopharmaBy RBC Capital Markets

  • 5
  • 5
  • 5
  • 5
  • 5

5

12 ratings


More shows like Pathfinders in Biopharma

View all
The Bill Simmons Podcast by The Ringer

The Bill Simmons Podcast

30,020 Listeners

RBC's Markets in Motion by RBC Capital Markets

RBC's Markets in Motion

40 Listeners

Industries in Motion by RBC Capital Markets

Industries in Motion

10 Listeners

Powering Sustainable Ideas by RBC Capital Markets

Powering Sustainable Ideas

0 Listeners

The Rest Is Politics by Goalhanger

The Rest Is Politics

3,038 Listeners

Macro Minutes by RBC Capital Markets

Macro Minutes

3 Listeners

Strategic Alternatives by RBC Capital Markets

Strategic Alternatives

19 Listeners

The Rest Is Politics: US by Goalhanger

The Rest Is Politics: US

2,136 Listeners